Eighteen members of the Lancet Diabetes & Endocrinology Commission met in Dubai for a meeting on Diabetes in sub-Saharan Africa. The event was hosted by the Harvard Medical School for Global Health Delivery–Dubai. The Commission, co-chaired by Drs. Rifat Atun and Edwin Gale, seeks to involve key actors to produce a comprehensive peer-reviewed document that will inform stakeholders involved in improving health systems in sub-Saharan Africa in the fight against diabetes.
The Commission works in the context of a growing epidemic of diabetes in sub-Saharan Africa, triggered by changes in lifestyle and nutritional habits due to rapid but uneven economic development, urbanization, and social transitions. Currently, diabetes is thought to affect 10.4 million people, or 3.1% of the total population, with 60% of patients thought to be undiagnosed—the highest rate of patients unaware of their diabetes status in the world. Type 1 diabetes is often fatal, and complications from both type 1 and type 2 diabetes take large numbers of otherwise productive people out of the workforce.
As part of the workshop program, the Center held an outreach event to help empower UAE and region-based doctors to submit their research to high-impact journals such as The Lancet. During the event, the commissioners were joined by 14 doctors and practitioners based in the UAE, who were able to listen to a series of presentations and speak to the commissioners. The Lancet Diabetes and Endocrinology Editor, Dr. Justine Davies; Drs. Rifat Atun and Edwin Gale and Commission members, Dr. Moffat Nyierenda, and Dr. Kaushik Ramaiya presented on a variety of topics, including writing for high-impact journals as well as their own work on diabetes.
View photos from the The Lancet Diabetes & Endocrinology Commission on Diabetes in sub-Saharan Africa.